Article
Predicting antifolate resistance in the unculturable fungal pathogen Pneumocystis jirovecii.
PLoS genetics - 1 May 2026
Rouleau Francois D, Dubé Alexandre K, Pageau Alicia, Désautels Lyne, Dufresne Philippe J, Landry Christian R
Abstract excerpt
Pneumocystis jirovecii is an opportunistic fungal pathogen responsible for Pneumocystis pneumonia (PCP) in immunocompromised patients. Antifolate drugs targeting the dihydrofolate reductase (DHFR), including trimethoprim (TMP), remain central to treatment, but studying the effects of mutations in DHFR on resistance to treatment is limited by our inability to culture this organism in vitro or in animal models. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
